Advertisement

Brain Metastases

  • John H. Suh
  • Gene H. Barnett
  • William F. Regine

Abstract

Brain metastases are a significant cause of morbidity and mortality that affects an estimated 20% to 30% of cancer patients [1]. The annual incidence in the United States has been estimated to be as high as 170,000 cases [2]. Brain metastases most commonly originate from tumors of the lung, breast, renal cells, and colon and from melanoma. In some cases, the primary is unknown. Multiple lesions are seen more frequently with melanoma and lung cancer, whereas single lesions are more common with breast, colon, and renal cell cancer. An estimated 30% to 40% of patients with a brain metastasis present with a single lesion [3].

Keywords

Brain Metastasis Clin Oncol Radiat Oncol Biol Phys Karnofsky Performance Status Radiation Therapy Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wen PY, Loeffler JS. Management of brain metastasis. Oncology (Huntingt) 1999; 13(7):941–954.Google Scholar
  2. 2.
    Greenberg H, Chandler WF, Sandler HM. Brain metastases. In Greenberg H, Chandler WF, Sandler HM, eds. Brain Tumors. Oxford: Oxford University Press, 1999:299–317.Google Scholar
  3. 3.
    Lohr F, Pirzkall A, Hof H, et al. Adjuvant treatment of brain metastases. Semin Surg Oncol 2001; 20:50–56.CrossRefPubMedGoogle Scholar
  4. 4.
    Zimm S, Wampler GL, Stablein D, et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981; 48(2):384–394.CrossRefPubMedGoogle Scholar
  5. 5.
    Posner JB. Intracranial metastases. Neurologic Complications of Cancer, vol. 45. Philadelphia: FA Davis Company, 1995:77–110.Google Scholar
  6. 6.
    Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastasis: histology, multiplicity, surgery and survival. Cancer 1996; 78:1781–1788.CrossRefPubMedGoogle Scholar
  7. 7.
    Hazra T, Mullins GM, Lott S. Management of cerebral metastases from bronchogenic carcinoma. Johns Hopkins Med J 1972; 130:377–383.PubMedGoogle Scholar
  8. 8.
    Chao JH, Phillips R, Nickson JJ. Roentgen-ray therapy of cerebral metastases. Cancer 1954; 7:682–689.CrossRefPubMedGoogle Scholar
  9. 9.
    Chu FCH, Hilaris BB. Value of radiation therapy on the management of intracranial metastases. Cancer 1961; 4:577–581.CrossRefGoogle Scholar
  10. 10.
    Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastasis: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6:1–9.PubMedGoogle Scholar
  11. 11.
    Gelber RD, Larson M, Borgelt BB, et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981; 48:1749–1753.CrossRefPubMedGoogle Scholar
  12. 12.
    Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high-dose irradiation schedules for the palliation of brain metastasis: final result of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981; 7:1633–1638.PubMedGoogle Scholar
  13. 13.
    Kurtz JM, Gelber R, Brady LW, et al. The palliation of brain metastasis in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981; 7:891–895.PubMedGoogle Scholar
  14. 14.
    Sause WT, Scott C, Krisch R, et al. Phase I/I1 trial of accelerated fractionation in brain metastasis RTOG 85-28. Int J Radiat Oncol Biol Phys 1993; 26:653–657.PubMedGoogle Scholar
  15. 15.
    Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionated versus standard in patients with unresected brain metastasis: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997; 39:571–574.PubMedGoogle Scholar
  16. 16.
    Komarnicky LT, Philips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG 7916). Int J Radiat Oncol Biol Phys 1991; 20:53–58.PubMedGoogle Scholar
  17. 17.
    Phillips TL, Scott CB, Leibel S et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastasis: a report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 1995; 33:339–348.PubMedGoogle Scholar
  18. 18.
    Sneed PK, Larson DA, Wara WM. Radiotherapy for cerebral metastases. Neurosurg Clin N Am 1996; 7:505–515.PubMedGoogle Scholar
  19. 19.
    Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951; 102:316–319.PubMedGoogle Scholar
  20. 20.
    Sturm V, Kober B, Hover KH, et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 1987; 13:279–282.PubMedGoogle Scholar
  21. 21.
    Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745–751.PubMedGoogle Scholar
  22. 22.
    Lagerwaald FJ, Levendag PC, Novak PJ, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795–801.Google Scholar
  23. 23.
    Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322:494–500.PubMedCrossRefGoogle Scholar
  24. 24.
    Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994; 29:711–717.PubMedGoogle Scholar
  25. 25.
    Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78:1470–1476.CrossRefPubMedGoogle Scholar
  26. 26.
    Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28:797–802.PubMedGoogle Scholar
  27. 27.
    Yu C, Chen JCT, Apuzzo MLJ, et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002; 52:1277–1287.CrossRefPubMedGoogle Scholar
  28. 28.
    Goyal LK, Suh JH, Reddy CA, et al. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastasis from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47:1007–1012.PubMedGoogle Scholar
  29. 29.
    Nieder C, Nestle U, Walter K, et al. Dose/effect relationships for brain metastases. J Cancer Res Clin Oncol 1998; 1214:346–350CrossRefGoogle Scholar
  30. 30.
    Leibel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1987; 66:1–22.CrossRefPubMedGoogle Scholar
  31. 31.
    Larson DA, Flickinger JC, Loeffler JS, et al. The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys 1993; 25:557–561.PubMedGoogle Scholar
  32. 32.
    Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastases. Int J Radiat Oncol Biol Phys 1997; 39:445–454.PubMedGoogle Scholar
  33. 33.
    Sperduto PW, Hall WA. Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope. Int J Radiat Oncol Biol Phys 1996; 36:511–513.PubMedGoogle Scholar
  34. 34.
    Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996; 35:27–35.PubMedGoogle Scholar
  35. 35.
    Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastases. J Neurosurg 1996; 84:748–754.CrossRefPubMedGoogle Scholar
  36. 36.
    O’Neill BP, Iturria NJ, Link MJ, et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003; 55:1169–1176.PubMedGoogle Scholar
  37. 37.
    Muacevic A, Kreth FW, Horstmann GA, et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999; 91:35–43.CrossRefPubMedGoogle Scholar
  38. 38.
    Loeffler JS, Shrieve DC. What is appropriate therapy for a patient with a single brain metastasis? Int J Radiat Oncol Biol Phys 1994; 29:915–917.PubMedGoogle Scholar
  39. 39.
    Weissman DE. Glucocorticoid treatment of brain metastases and epidural spinal cord compression: a review. J Clin Oncol 1988; 6:543–551.PubMedGoogle Scholar
  40. 40.
    Loeffler JS, Kooy HM, Wen PW, et al. The treatment of recurrent brain metastasis with stereotactic radiosurgery. J Clin Oncol 1990; 8:576–582.PubMedGoogle Scholar
  41. 41.
    Alexander E 3rd, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastasis. J Natl Cancer Inst 1995; 87:34–40.CrossRefPubMedGoogle Scholar
  42. 42.
    Breneman JC, Warnick RE, Albright RE Jr, et al. Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series. Cancer 1997; 79:551–557.CrossRefPubMedGoogle Scholar
  43. 43.
    Noël G, Proudhom MA, Valery CA, et al. Radiosurgery for reirradiation of brain metastases: results in 54 patients. Radiother Oncol 2001; 60:61–67.CrossRefPubMedGoogle Scholar
  44. 44.
    Kihlstrom L, Karlsson B, Lindquist C. Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact Funct Neurosurg 1993; 61:45–50.CrossRefPubMedGoogle Scholar
  45. 45.
    Valentino V. The results of radiosurgical management of 139 single cerebral metastases. Acta Neurochir (Suppl) 1995; 63:95–100.Google Scholar
  46. 46.
    Shiau CY, Sneed PK, Shu HK, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997; 37:375–383.PubMedGoogle Scholar
  47. 47.
    Matsuo T, Shibata S, Yasunaga A, et al. Dose optimization and indication of Linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 1999; 45:931–939.PubMedGoogle Scholar
  48. 48.
    Schoeggl A, Kitz K, Ertl A, et al. Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients. J Neurooncol 1999; 42:168–175.CrossRefGoogle Scholar
  49. 49.
    Simonova G, Liscak R, Novotny J. Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. Radiother Oncol 2000; 57:207–213.CrossRefPubMedGoogle Scholar
  50. 50.
    Chidel MA, Suh JH, Reddy CA, et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000; 47:993–999.PubMedGoogle Scholar
  51. 51.
    Joseph J, Adler JR, Cox RS, et al. Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 1996; 14:1085–1092.PubMedGoogle Scholar
  52. 52.
    Shehata MK, Young B, Reid B, et al. Stereotactic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 2004;59:87–93.PubMedGoogle Scholar
  53. 53.
    Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998; 16:3563–3569.PubMedGoogle Scholar
  54. 54.
    Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999; 43:549–558.PubMedGoogle Scholar
  55. 55.
    Sanghavi SN, Miranpuri SS, Chappell R, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001; 51:426–434.PubMedGoogle Scholar
  56. 56.
    Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45:427–434.PubMedGoogle Scholar
  57. 57.
    Chougule P, Burton-Williams M, Saris S, et al. Randomized treatment of brain metastasis with Gamma Knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 2000; 48(Suppl):114.Google Scholar
  58. 58.
    Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363:1622–1672.CrossRefGoogle Scholar
  59. 59.
    DeAngelis LM, Posner LB. Radiation-induced dementia in patients cured brain metastases. Neurology 1989; 39:789–796.PubMedGoogle Scholar
  60. 60.
    So NK, O’Neill BP, Frytak S, et al. Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology 1987; 37:1198–1201.PubMedGoogle Scholar
  61. 61.
    Cox JD, Stanley K, Petrovich Z, et al. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245:469–472.CrossRefPubMedGoogle Scholar
  62. 62.
    Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991; 21:637–643.PubMedGoogle Scholar
  63. 63.
    Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984; 2:253–259.CrossRefPubMedGoogle Scholar
  64. 64.
    Mamon HJ, Yeap BY, Reblando J, et al. High risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005; 23:1530–1537.CrossRefPubMedGoogle Scholar
  65. 65.
    Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004; 22:157–165.CrossRefPubMedGoogle Scholar
  66. 66.
    Regine WF, Scott C, Murray K, et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated hyperfractionation radiotherapy: an analysis from the Radiation Therapy Oncology Group 91-04. Int J Radiat Oncol Biol Phys 2001; 51:711–717.PubMedGoogle Scholar
  67. 67.
    Chang EL, Wefel JS, Meyers CA, et al. Prospective neurocognitive evaluation of patients with 1 to 3 newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 2004; 60:S164–S165.CrossRefGoogle Scholar
  68. 68.
    Regine WF, Schmitt FA, Scott CB, et al. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 2004; 58:1346–1352.CrossRefPubMedGoogle Scholar
  69. 69.
    Sonderkaer S, Schmiegelow M, Carstensen H, et al. The long-term neurologic outcome of childhood brain tumors treated by surgery alone. J Clin Oncol 2003; 21:1347–1351.CrossRefPubMedGoogle Scholar
  70. 70.
    Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003; 21:4175–4183.CrossRefPubMedGoogle Scholar
  71. 71.
    Schagen SB, van Dam FSAM, Muller MJ, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer. Cancer 1999; 85:640–650.CrossRefPubMedGoogle Scholar
  72. 72.
    van Dam FSAM, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: high-dose versus standard dose chemotherapy. J Natl Cancer Inst 1998; 90:210–218.CrossRefPubMedGoogle Scholar
  73. 73.
    Brezden CB, Phillips KA, Abdolell M, et al. Qaeda to function and breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18:2695–2701.PubMedGoogle Scholar
  74. 74.
    Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280:1485–1489.CrossRefPubMedGoogle Scholar
  75. 75.
    Patchell RA, Regine WF. The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol Ca Res Treat 2003; 2:111–115.Google Scholar
  76. 76.
    Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002; 52:333–338.PubMedGoogle Scholar
  77. 77.
    Hasegawa T, Kondziolka D, Flickinger JC, et al. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 2003; 52:1318–1326.CrossRefPubMedGoogle Scholar
  78. 78.
    Lutterbach J, Cyron D, Henne K, et al. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 2003; 52:1066–1074.CrossRefPubMedGoogle Scholar
  79. 79.
    Sneed PK, Suh JH, Goesch SJ, et al. A multi-institutional review of radiosurgery alone versus radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002; 53:519–526.PubMedGoogle Scholar
  80. 80.
    Manon RR, Oneill A, Mehta M, et al. Phase II trial of radiosurgery (RS) for 1–3 newly diagnosed brain metastases from renal cell, melanoma, and sarcoma: An Eastern Cooperative Oncology Group Study (E6397). Proceedings of the 40th ASCO meeting [abstract no. 1507]. J Clin Oncol 2004.Google Scholar
  81. 81.
    Aoyama H, Shirato H, Nakagawa K, et al. Interim report of the JROSG99-1 multi-institutional randomized trial, comparing radiosurgery alone versus radiosurgery plus whole brain irradiation for 1–4 brain metastases. Proceedings of the 40th ASCO meeting [abstract no. 1506]. J Clin Oncol 2004.Google Scholar
  82. 82.
    Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47:291–298.CrossRefPubMedGoogle Scholar
  83. 83.
    Shaw E, Scott C, Souhami L, et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of the Radiation Therapy Oncology Group protocol 90-05. Int J Radiat Oncol Biol Phys 1996; 34:647–654.PubMedGoogle Scholar
  84. 84.
    Valery CA, Cornu P, Noël G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 2003; 81:115–119.CrossRefPubMedGoogle Scholar
  85. 85.
    Warnick RE, Darakchiev BJ, Breneman JC. Stereotactic radiosurgery for patient with solid brain metastases: current status. J Neuro-oncol 2004; 69:125–137.CrossRefGoogle Scholar
  86. 86.
    Ma L, Chin LS, DiBiase SJ, et al. Concomitant boost of stratified target area with gamma knife radiosurgery: a treatment planning study. Am J Clin Oncol 2003; 26:e100–e105.CrossRefPubMedGoogle Scholar
  87. 87.
    Levivier M, Massager N, Wikler D, et al. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med 2004; 45:1146–1154.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • John H. Suh
    • 1
  • Gene H. Barnett
    • 2
    • 3
  • William F. Regine
    • 4
  1. 1.Department of Radiation OncologyCleveland ClinicClevelandUSA
  2. 2.Cleveland Clinic Lerner College of MedicineUSA
  3. 3.Brain Tumor InstituteCleveland ClinicClevelandUSA
  4. 4.Department of Radiation OncologyUniversity of Maryland Medical SchoolBaltimoreUSA

Personalised recommendations